Possible involvement of cytokine gene polymorphisms in fulminant hepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 8, 2007, Pages 1271-1277

  Takakura, Mihoko ^a   Tokushige, Katsutoshi ^a,b   Matsushita, Noriko ^a   Hashimoto, Etsuko ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Fulminant hepatitis; IL 10; SNP; TNF ; TNF

Indexed keywords

CYTOKINE; INTERLEUKIN 10; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; HAPLOTYPE; HEPATITIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION;

EID: 34547679445     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04846.x     Document Type: Article

References (29)

1. Sekiyama KD, Yoshiba M, Thomson W. Circulating proinflammatory cytokines (IL1-β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant failure and acute hepatitis. Clin. Exp Immunol. 1994 98 : 71 7.
2. Muto Y, Nouri-Aria K, Meager A, Alexander GJM, Eddleston ALWF, Williams R. Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 1988 2 : 72 4.
3. De la Mata M, Meager A, Roland N et al. Tumor necrosis factor production in fulminant hepatic failure: relation to etiology and superimposed microbial infection. Clin. Exp. Immunol. 1990 82 : 479 84.
4. Trautwein C, Rakemann T, Brenner DA et al. Concanavalin A-induced liver cell damage. Activation of intracellular pathway triggered by tumor necrosis factor in mice. Gastroenterology 1998 114 : 1035 45.
5. Tokushige K, Yamauchi N, Ikeda I, Hashimoto E, Yamauchi K, Hayashi N. Significance of soluble TNF receptor-1 in acute-type fulminant hepatitis. Am. J. Gastroenterol. 2000 95 : 2040 6.
6. Wilson AG, de Giovine FS, Duf GW. Genetics of TNF-α in autoimmune, infectious and neoplastic disease. J. Inflamm. 1995 45 : 1 12.
7. Pociot F, Bariant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility alleles with the secretion of TNF alpha and TNF beta by human mononuclear cells; a possible link to insulin dependent diabetes mellitus. Eur. J. Immunol. 1993 23 : 224 31.
8. McGuire W, Hill AVS, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in TNF-αpromoter region associated with susceptibility to cerebral malaria. Nature 1994 371 : 508 11.
9. McGuire W, Knight JC, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect Dis. 1999 179 : 287 90.
10. Negoro K, Kinouchi Y, Hiwatashi N et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of tumor necrosis factor gene. Gastroenterology 1999 117 : 1062 8.
11. Tsuchiya N, Tokushige K, Yamaguchi N et al. Influence of TNF gene polymorphism in patients with acute and fulminant hepatitis. J Gastroenterol. 2004 39 : 859 66.
12. Miyazoe S, Hamasaki K, Nakata K et al. Influence of Interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 2002 97 : 2086 92.
13. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to Interferon alfa. Hepatology 1999 30 : 526 30.
14. Yee LJ, Tang JM, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 2001 33 : 708 12.
15. Takahashi Y, Shimizu M. The Study Group of fulminant hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicenter study. J. Gastroenterol. Hepatol. 1991 6 : 159 64.
16. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha gene detectable by Nco1 restriction of PCR product. Hum. Mol. Genet. 1992 1 : 353.
17. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D. Primary biliary cirrhosis shows association with genetic polymorphism of tumor necrosis factor alpha promoter region. J. Hepatol. 1999 31 : 242 7.
18. Bernal W, Donaldson P, Underhill J, Wendon J, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol) -induced acute liver failure. J. Hepatol. 1998 29 : 53 9.
19. Stuber F, Peterson M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit. Care Med. 1996 24 : 381 4.
20. Tokushige K, Tsuchiya N, Hasegawa K et al. Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV. Am. J. Gastroenterol. 2003 98 : 160 6.
21. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5'-flanking region of the human tumor factor (TNF)-α gene in Japanese. Tissue Antigens 1998 51 : 605 12.
22. Yee LJ, Tang JM, Herrera J, Kaslow RA, Vanleeuwen DJ. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun. 2000 1 : 386 90.
23. Nagaki M, Tanaka M, Sugiyama A, Ohnishi H, Moriwaki H. Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alfa and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice. J. Hepatol. 1999 31 : 815 24.
24. Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H. High level of serum Interleukin-10 and Tumor Necrosis Factor-α are associated with fatality in fulminant hepatitis. J. Infect Dis. 2000 182 : 1103 8.
25. Seki T, Ota M, Furuta S et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992 103 : 1041 7.
26. Fujiwara K, Yokosuka O, Imazeki F et al. Analysis of the genotype-determining region of hepatitis A virul RNA in relation to disease severities. Hepatol. Res. 2003 25 : 124 34.
27. Joh R, Hasegawa K, Ogawa M et al. Genotypic analysis of hepatitis B virus from patients with fulminant hepatitis: comparison with acute self-limited hepatitis. Hepatol. Res. 2003 26 : 119 24.
28. Yoshiba M, Dehara K, Inoue K, Okamoto H, Mayumi M. Contribution of hepatitis C virus to non-A, non-B, fulminant hepatitis in Japan. Hepatology 1994 19 : 829 35.
29. Yoshiba M, Sekiyama K, Inoue K et al. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study. J. Gastroenterol. 2002 37 : 916 21.